指南与共识重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症COVID-19患者管理临床实践指南推荐意见与WHO指南的一致性研究

Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients.
指南 / 共识 · Eur J Hosp Pharm · 2020-07-31
一句话结论截至2020年4月30日,各临床实践指南与WHO指南在重症COVID-19管理推荐方向上的一致性仅7.7%,排除证据不足条目后升至61.5%,不一致主要可由UpToDate来源解释。

该研究系统比较了截至2020年4月30日发表的临床实践指南及UpToDate即时资源与WHO指南在重症COVID-19患者管理中的推荐一致性。从WHO指南中提取13条参考推荐,结果显示各指南与WHO方向一致性率为7.7%;排除标注证据不足的推荐后一致性升至61.5%。去掉UpToDate后一致性绝对变化23.1%(从1/13即7.7%升至4/13即30.8%),提示UpToDate来源可解释不一致。作者认为这些不一致应由相关机构达成共识,以免临床实践混乱,同时等待临床试验提供最佳实践依据。

要点

  • 截至2020年4月30日,各临床实践指南与WHO指南在重症COVID-19管理推荐方向上的一致性仅7.7%(1/13)。
  • 排除标注证据不足的推荐后,一致性率升至61.5%。
  • 去掉UpToDate来源后一致性绝对变化23.1%(从1/13即7.7%升至4/13即30.8%),提示UpToDate可解释不一致。
  • 作者认为不一致应由相关机构达成共识,以避免临床实践混乱,同时等待临床试验结果。

适用人群与场景

  • 重症COVID-19患者的管理推荐,纳入截至2020年4月30日发表的临床实践指南及UpToDate即时资源,与WHO指南进行比较。

研究设计与关键结果

  • 研究类型为对临床实践指南及UpToDate即时资源的系统比较,比较对象为WHO指南,共生成13条参考推荐,每条明确规定了人群、干预和对照状态。
  • 各指南与WHO推荐方向的一致性率为7.7%(1/13)。
  • 排除标注证据不足的推荐后,一致性率升至61.5%。
  • 留一法敏感性分析提示UpToDate推荐来源可解释不一致:去掉UpToDate后一致性率绝对变化23.1%,从1/13(7.7%)升至4/13(30.8%)。

证据类型、等级与局限

  • 证据类型:对临床实践指南和UpToDate即时资源的系统比较分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,各指南与WHO推荐之间的不一致应由相关机构达成共识,以避免临床实践混乱,同时等待临床试验提供最佳实践依据。

指南或共识出处

  • WHO关于重症COVID-19患者管理的临床实践指南(原文未注明具体指南名称与发布年份)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: A significant knowledge gap exists for the management of critically ill patients with coronavirus disease 2019 (COVID-19). This study aimed to systematically investigate the consistency of recommendations from the available clinical practice guidelines (CPGs) to those of the WHO on the management of critically ill COVID-19 patients.

METHODS: We examined CPGs and UpToDate point-of-care resources on the management of critically ill COVID-19 patients that had been published as of 30 April 2020 and compared them against the CPG by the WHO. The main outcome was the rate of consistency among CPGs for the management of critically ill COVID-19 patients. Sensitivity analyses were conducted by excluding recommendation statements that were described as insufficient evidence and by excluding single CPGs one at a time.

RESULTS: Thirteen reference recommendations derived from the CPG of the WHO were generated using discrete and unambiguous specifications of the population, intervention, and comparison states. Across CPGs, the rate of consistency in direction with the WHO is 7.7%. When insufficient evidence codings were excluded, the rate of consistency increased substantially to 61.5%. The results of a leave-one-out sensitivity analysis suggested that the UpToDate recommendation source could explain the inconsistency. Consistency in direction rates changed by an absolute 23.1% (from 1/13 (7.7%) to 4/13 (30.8%)) if UpToDate was removed.

CONCLUSIONS: We observed inconsistencies between some recommendations of the CPGs and those of the WHO. These inconsistencies should best be addressed by consensus among the relevant bodies to avoid confusion in clinical practice while awaiting clinical trials to inform us of the best practice.

来源:Eur J Hosp Pharm,查看原文。版权归原作者所有。

参考来源

  1. Kow CS, Capstick T, Zaidi STR, et al. Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients. Eur J Hosp Pharm. 2020. PMID: 32737069. doi:10.1136/ejhpharm-2020-002388

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。